Rebecca Smith
Critical Care Medicine · Birmingham, ALNPI 1396470423
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $338 of the $428 with a category attached, or 79.0%. 8 manufacturers reported payments, led by Johnson & Johnson at 30.0% of the total. 2025 is the largest year on record at $394, more than ten times the $20 reported in 2023.
Across 17 payments — averaging $25.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$128
- AbbVie$89
- Pfizer$47
- AstraZeneca$45
- Motiva USA, LLC$41
- Atland Pharmaceuticals, LLC$40
- plus $38 from 2 others
What the payments were for
- Food & beverage$33879%
- Education$9021%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 3 | $128 |
| AbbVie | 4 | $89 |
| Pfizer | 3 | $47 |
| AstraZeneca | 2 | $45 |
| Motiva USA, LLC | 2 | $41 |
| Atland Pharmaceuticals, LLC | 1 | $40 |
| Convatec Inc. | 1 | $20 |
| UCB, Inc. | 1 | $17 |
How this compares
$428 in reported general payments places this provider in the 55th percentile of 73 critical care medicine providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylprednisolone | 19 | $161 |
Paid to pharmacies, not to this prescriber.
Other critical care medicine in Birmingham
- James WellsBirmingham$223K
- Mark DransfieldBirmingham$160K
- George SolomonBirmingham$113K
- Tracy LuckhardtBirmingham$28K
- Keith WilleBirmingham$9K
- Victor ThannickalBirmingham$8K
- Vipul ShahBirmingham$6K
- Samuel McElweeBirmingham$5K
- Nicole SchreinerBirmingham$4K
- David LafonBirmingham$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.